Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2004-08-24 - 1004-10-27
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2004
Report date:
2004

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Version / remarks:
OECD 406 (1992)
GLP compliance:
yes (incl. QA statement)
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
At the time of study performance the LLNA was not the current standard test method.

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
477-690-9
EC Name:
-
Cas Number:
874819-71-3
Molecular formula:
Hill formula: C6H9N4O3P CAS formula: C6H9N4O3P
IUPAC Name:
N-(diaminophosphoryl)-2-nitroaniline
Test material form:
solid: crystalline

In vivo test system

Test animals

Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
male
Details on test animals and environmental conditions:
Species/strain: Guinea-pig/Dunkin Hartley, Crl:(HA)BR
Sex: male
Supplier: Charles River Wiga GmbH, D-97320 Sulzfeld
Age: 16 days

Study design: in vivo (non-LLNA)

Inductionopen allclose all
Route:
other: intracutaneous induction
Vehicle:
other: 0.5% solution of Tylose MH 1000 in deionised water
Concentration / amount:
Concentration of test material and vehicle used at induction:
Induction: i.c.: 5 % (w/v) suspesion in a 0.5 % (m/v) of Tylose in deionised water

solution of Tylose MH 1000 in

deionised water

Induction: e.c.: 25 % (w/w) mixture of the test item with

vaseline

Concentration of test material and vehicle used for each challenge:
25 % (w/w) mixture of the test item with vaseline
Challengeopen allclose all
Route:
epicutaneous, occlusive
Vehicle:
other: 0.5% solution of Tylose MH 1000 in deionised water
Concentration / amount:
Concentration of test material and vehicle used at induction:
Induction: i.c.: 5 % (w/v) suspesion in a 0.5 % (m/v) of Tylose in deionised water

solution of Tylose MH 1000 in

deionised water

Induction: e.c.: 25 % (w/w) mixture of the test item with

vaseline

Concentration of test material and vehicle used for each challenge:
25 % (w/w) mixture of the test item with vaseline
No. of animals per dose:
Number of animals in test group: 10
Number of animals in negative control group: 5
Positive control substance(s):
not required

Results and discussion

In vivo (non-LLNA)

Resultsopen allclose all
Key result
Reading:
1st reading
Hours after challenge:
48
Group:
test chemical
Dose level:
25 %
No. with + reactions:
1
Total no. in group:
10
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 25 %. No with. + reactions: 1.0. Total no. in groups: 10.0.
Key result
Reading:
2nd reading
Hours after challenge:
72
Group:
test chemical
Dose level:
25 %
No. with + reactions:
1
Total no. in group:
10
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: test group. Dose level: 25 %. No with. + reactions: 1.0. Total no. in groups: 10.0.
Key result
Reading:
1st reading
Hours after challenge:
48
Group:
negative control
Dose level:
25 %
No. with + reactions:
0
Total no. in group:
5
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
Key result
Reading:
2nd reading
Hours after challenge:
72
Group:
negative control
Dose level:
25 %
No. with + reactions:
0
Total no. in group:
5
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 72.0. Group: negative control. Dose level: 25 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
Key result
Reading:
1st reading
Hours after challenge:
48
Group:
positive control
Dose level:
25%
No. with + reactions:
10
Total no. in group:
10
Key result
Reading:
2nd reading
Hours after challenge:
72
Group:
positive control
Dose level:
25%
No. with + reactions:
10
Total no. in group:
10

Any other information on results incl. tables

Maximum concentration not causing irritating effects in preliminary test: 25 %

Signs of irritation during induction:
only after i.c. induction: oedema

Evidence of sensitisation of each challenge concentration:
The administration of the 25 % (w/w) mixture of the test
item with vaseline caused only a slight erythema in one of
the ten animals of the dose group on day 23.

Number of animals with skin sensitisation reaction after administration of N(2-Nitrophenyl)phosphoric triamide

(left flank: control; right flank: test item)

Test group

Time after challenge

48hours (Day23)

72hours (Day24)

Left flank

Right flank

Left flank

Right flank

Animals with skin sensitisation reaction/used animals

Control group

0/5

0/5

0/5

0/5

Dose group

0/10

1 / 10

0/10

1 / 10

from this

 

 

 

 

grade 1

 

1/10

 

1 / 10


Applicant's summary and conclusion

Interpretation of results:
not sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
N-(2-Nitrophenyl)phosphoric triamide is not a skin sensitiser.
Executive summary:

The skin sensitisation potential of the test item N-(2-Nitrophenyl)phosphoric triamide was

investigated in the Guinea-Pig Maximisation Test with the Dunkin Hartley albino strain, whose sensitivity to Benzocaine had been demonstrated, according to OECD guideline 406.

The choice of doses for the main experiment based on the results of the pilot study.

None of the animals died or showed clinical signs during the course of investigation.

The body weights and the body weight gain were not affected by the treatment.

The intracutaneous injection of the 5 % (w/v) suspension of the test item in a 0.5 % Xylose solution induced oedema. In combination with sensitisation potentiating FCA slight to moderate erythema and oedema were observed.

The epicutaneous administration of the 25 % (w/w) mixture of the test item with vaseline did not cause any irritation signs.

The challenge with the 25 % (w/w) mixture of the test item with vaseline caused only a slight erythema in one of the ten animals of the dose group.

The skin fold thickness was not affected by the challenge.